awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q47095910-3E4107F1-C452-4C8C-B2BB-EADBBAFDED28
Q47095910-3E4107F1-C452-4C8C-B2BB-EADBBAFDED28
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47095910-3E4107F1-C452-4C8C-B2BB-EADBBAFDED28
Long-term efficacy and safety in patients with rheumatoid arthritis continuing on SB4 or switching from reference etanercept to SB4.
P2860
Q47095910-3E4107F1-C452-4C8C-B2BB-EADBBAFDED28
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47095910-3E4107F1-C452-4C8C-B2BB-EADBBAFDED28
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0bba5e645d3c11e289351b5cadaedbcf6412ef12
P2860
A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy.